IFG Advisory’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-833
| Closed | -$5.1K | – | 473 |
|
|
2023
Q4 | $5.1K | Hold |
833
| – | – | ﹤0.01% | 575 |
|
|
2023
Q3 | $3.89K | Hold |
833
| – | – | ﹤0.01% | 536 |
|
|
2023
Q2 | $4.47K | Hold |
833
| – | – | ﹤0.01% | 323 |
|
|
2023
Q1 | $8.2K | Sell |
833
-137
| -14% | -$1.35K | ﹤0.01% | 509 |
|
|
2022
Q4 | $18K | Hold |
970
| – | – | ﹤0.01% | 486 |
|
|
2022
Q3 | $20K | Hold |
970
| – | – | ﹤0.01% | 511 |
|
|
2022
Q2 | $20K | Hold |
970
| – | – | ﹤0.01% | 458 |
|
|
2022
Q1 | $41K | Buy |
970
+87
| +10% | +$3.68K | ﹤0.01% | 485 |
|
|
2021
Q4 | $52K | Hold |
883
| – | – | 0.01% | 493 |
|
|
2021
Q3 | $75K | Hold |
883
| – | – | 0.01% | 475 |
|
|
2021
Q2 | $98K | Buy |
+883
| New | +$98K | 0.01% | 466 |
|
|
2020
Q3 | – | Sell |
-9,770
| Closed | -$3.16M | – | 412 |
|
|
2020
Q2 | $3.16M | Buy |
9,770
+4
| +0% | +$1.29K | 0.57% | 41 |
|
|
2020
Q1 | $871K | Buy |
+9,766
| New | +$871K | 0.19% | 125 |
|